DMAC
DiaMedica Therapeutics Inc
8.00$
-1.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 46.2% | 9.2% | – | – | – | – | 0.0% | – | – | – | 0.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -46.2% | -9.2% | – | – | – | – | 0.0% | – | – | – | -0.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 240.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 15,038.5% | 2,157.9% | – | – | – | – | 11.9% | – | – | – | 46.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 154.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10,838.5% | 1,957.9% | – | – | – | – | 7.0% | – | – | – | 14.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 394.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 25,876.9% | 4,115.8% | – | – | – | – | 19.0% | – | – | – | 61.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -281.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -25,876.9% | -4,115.8% | – | – | – | – | -19.0% | – | – | – | -61.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 1.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | – | – | – | – | 18.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -93.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -25,776.9% | -4,015.8% | – | – | – | – | -16.7% | – | – | – | -57.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 11.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 53.8% | 9.2% | – | – | – | – | 0.1% | – | – | – | 0.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -104.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -25,830.8% | -4,025.0% | – | – | – | – | -16.7% | – | – | – | -57.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -294.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -25,730.8% | -4,006.6% | – | – | – | – | -16.6% | – | – | – | -57.1% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.